Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tore Bach-Gansmo

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 30, 2017
Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody-Radionuclide Conjugate <sup>177</sup>Lu-Lilotomab SatetraxetanJohan Blakkisrud, Jon Erik Holtedahl, Ayca Løndalen, et al.
Thyroid : Official Journal of the American Thyroid Association|May 22, 2023
<i>Letter to the Editor:</i> Repeat Redifferentiation of Radioiodine Refractory BRAF<sup>V600E</sup> Mutated Thyroid Cancer with DabrafenibTrond Bogsrud, Marita Jacobsen, Jolanta Durski, et al.
Anticancer Research|December 25, 2009
Establishment and characterization of a human gastrointestinal stromal tumour (GIST) xenograft in athymic nude miceMona-Elisabeth Revheim, Therese Seierstad, Jeanne-Marie Berner, et al.
The Lancet. Oncology|November 2, 2019
What is the best PET target for early biochemical recurrence of prostate cancer?-Authors' replyJeremie Calais, Francesco Ceci, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 6, 2016
Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab SatetraxetanJohan Blakkisrud, Ayca Løndalen, Anne C T Martinsen, et al.
European Journal of Radiology|June 6, 2015
Respiratory gated PET/CT of the liver: A novel method and its impact on the detection of colorectal liver metastasesAnselm Schulz, Johannes Clemens Godt, Johann Baptist Dormagen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2022
Glioblastoma PET/MRI: kinetic investigation of [<sup>18</sup>F]rhPSMA-7.3, [<sup>18</sup>F]FET and [<sup>18</sup>F]fluciclovine in an orthotopic mouse model of cancerMarcel Lindemann, Ana Oteiza, Montserrat Martin-Armas, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|December 2, 2015
Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRIAnselm Schulz, Ellen Viktil, Johannes Clemens Godt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 12, 2019
[<sup>18</sup>F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0Cristina Nanni, Lucia Zanoni, Tore Bach-Gansmo, et al.
The Journal of Urology|October 18, 2016
Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (<sup>18</sup>F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate CancerTore Bach-Gansmo, Cristina Nanni, Peter T Nieh, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 30, 2017
Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody-Radionuclide Conjugate <sup>177</sup>Lu-Lilotomab SatetraxetanJohan Blakkisrud, Jon Erik Holtedahl, Ayca Løndalen, et al.
Thyroid : Official Journal of the American Thyroid Association|May 22, 2023
<i>Letter to the Editor:</i> Repeat Redifferentiation of Radioiodine Refractory BRAF<sup>V600E</sup> Mutated Thyroid Cancer with DabrafenibTrond Bogsrud, Marita Jacobsen, Jolanta Durski, et al.
Anticancer Research|December 25, 2009
Establishment and characterization of a human gastrointestinal stromal tumour (GIST) xenograft in athymic nude miceMona-Elisabeth Revheim, Therese Seierstad, Jeanne-Marie Berner, et al.
The Lancet. Oncology|November 2, 2019
What is the best PET target for early biochemical recurrence of prostate cancer?-Authors' replyJeremie Calais, Francesco Ceci, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 6, 2016
Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab SatetraxetanJohan Blakkisrud, Ayca Løndalen, Anne C T Martinsen, et al.
European Journal of Radiology|June 6, 2015
Respiratory gated PET/CT of the liver: A novel method and its impact on the detection of colorectal liver metastasesAnselm Schulz, Johannes Clemens Godt, Johann Baptist Dormagen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2022
Glioblastoma PET/MRI: kinetic investigation of [<sup>18</sup>F]rhPSMA-7.3, [<sup>18</sup>F]FET and [<sup>18</sup>F]fluciclovine in an orthotopic mouse model of cancerMarcel Lindemann, Ana Oteiza, Montserrat Martin-Armas, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|December 2, 2015
Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRIAnselm Schulz, Ellen Viktil, Johannes Clemens Godt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 12, 2019
[<sup>18</sup>F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0Cristina Nanni, Lucia Zanoni, Tore Bach-Gansmo, et al.
The Journal of Urology|October 18, 2016
Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (<sup>18</sup>F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate CancerTore Bach-Gansmo, Cristina Nanni, Peter T Nieh, et al.
Pageof 4